AstraZenecaGaithersburg, Maryland, United States
Disclosure information not submitted.
185 - Nirsevimab Binding Site Conservation in RSV F Protein between 2019 and 2024: Analysis of Sequencing Data from the US OUTSMART-RSV Surveillance Study and Public Databases
Monday, October 20, 20252:45 PM - 2:57 PM US ET